Circulating adrenomedullin estimates survival and reversibility of organ failure in sepsis: the prospective observational multinational Adrenomedullin and Outcome in Sepsis and Septic Shock-1 (AdrenOSS-1) studyPierre‐François Laterre, Haikel Oueslati, Peter Pickkers et al.|Critical Care|2018Cited by 134
Circulating Dipeptidyl Peptidase 3 is a Myocardial Depressant Factor: Dipeptidyl Peptidase 3 Inhibition Rapidly and Sustainably Improves HaemodynamicsBenjamin Deniau, Alice Blet, Linda Rehfeld et al.|European Journal of Heart Failure|2019Cited by 106
Circulating Dipeptidyl Peptidase 3 and Alteration in Haemodynamics in Cardiogenic Shock: Results from the OptimaCC TrialKoji Takagi, Antoine Kimmoun, Alice Blet et al.|European Journal of Heart Failure|2019Cited by 97
Bromocriptine for the treatment of peripartum cardiomyopathy: welcome on BOARDMattia Arrigo, Alexandre Mebazaa, Alice Blet|European Heart Journal|2017Cited by 83
Monitoring circulating dipeptidyl peptidase 3 (DPP3) predicts improvement of organ failure and survival in sepsis: a prospective observational multinational studyAlexandre Mebazaa, Alice Blet, Benjamin Deniau et al.|Critical Care|2021Cited by 79